InspireMD Inc. has announced the appointment of Michael Lawless as its new Chief Financial Officer, effective by June 30, 2025. Lawless, with extensive experience in healthcare finance, previously served as CFO at Lifeward and will succeed Craig Shore, who held the position for nearly 15 years. Lawless is expected to contribute to InspireMD's continued growth and the upcoming U.S. launch of the CGuard Prime carotid stent system.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.